Luca Mazzucchelli

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice

Elisabetta Traggiai, Laurie Chicha, Luca Mazzucchelli et al. · Science · 2004 · 976 citations

Life Sciences, Developmental Biology, Immunology +17

<i>PIK3CA</i> Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Andrea Sartore‐Bianchi, Miriam Martini, Francesca Molinari et al. · Cancer Research · 2009 · 739 citations

Medicine, Oncology, Pharmacology +17

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

Milo Frattini, Piercarlo Saletti, Elena Romagnani et al. · British Journal of Cancer · 2007 · 538 citations · Full text

Medicine, Oncology, Pharmacology +17